(Q36558688)

14 August 2017

1 reference

title

Current treatment approaches to early childhood medulloblastoma (English)

1 reference

14 August 2017

0 references

Stefan Rutkowski

1

1 reference

14 August 2017

1 August 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

8

1 reference

14 August 2017

1211-1221

1 reference

Population-based epidemiologic data on brain tumors in German children

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Medulloblastoma: molecular genetics and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Medulloblastoma: present concepts of stratification into risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Chemotherapy of central nervous system tumours in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Intellectual outcome in children with malignant tumors of the posterior fossa: influence of the field of irradiation and quality of surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Is there a danger in delaying radiotherapy in childhood medulloblastoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

The change in patterns of relapse in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

High-dose chemotherapy in childhood brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

21 January 2018

Intrathecal chemotherapy

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: Prolonged remission with the ommaya reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Intrathecal mafosfamide: a preclinical pharmacology and phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

The therapy of infantile malignant brain tumors: current status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Current approaches to CNS tumors in infants and very young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

MOPP regimen as primary chemotherapy for brain tumors in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Measuring the neuro-cognitive side-effects of irradiation in children with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

The long-term effects of cranial irradiation on the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Late neurocognitive sequelae in survivors of brain tumours in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Brain tumor chemotherapy with methotrexate given intrathecally. A new technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Biochemical and Clinical Aspects of Methotrexate Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Intrathecal methotrexate affects cognitive function in children with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Necrotizing Encephalopath Following Intraventricular Instillatio of Methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Classifying the medulloblastoma: insights from morphology and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Molecular pathogenesis of childhood brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1211

10.1586/14737175.6.8.1211

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16893348